ABO-incompatible liver transplantation using only rituximab for patients with low anti-ABO antibody titer

BACKGROUNDS/AIMS: Graft survival after ABO-incompatible (ABOi) living donor liver transplantation (LDLT) has increased due to advances in desensitization methods. We analyzed early outcomes following ABOi LDLT using only rituximab without any additional desensitization methods in recipients with low...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Boram, Choi, YoungRok, Han, Ho-Seong, Yoon, Yoo-Seok, Cho, Jai Young, Jeong, Sook-Hyang, Kim, Jin-Wook, Jang, Eun Sun, Ahn, Soomin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Hepato-Biliary-Pancreatic Surgery 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728259/
https://www.ncbi.nlm.nih.gov/pubmed/31501808
http://dx.doi.org/10.14701/ahbps.2019.23.3.211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728259/
https://www.ncbi.nlm.nih.gov/pubmed/31501808
http://dx.doi.org/10.14701/ahbps.2019.23.3.211

Ejemplares similares